99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Host-microbe interactions in the gut: Target for drug therapy, opportunity for drug discovery

Clinical and Experimental Immunology

Volumn 160, Issue 1, 2010, Pages 92-97

  Shanahan, F ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Immunity; Inflammatory bowel disease; Lifestyle; Microbiota

Indexed keywords

BACTERIOCIN; DRUG; LACTICIN 3147; METRONIDAZOLE; THURICIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ALLERGIC DISEASE; ANIMAL HUSBANDRY; COMPARATIVE STUDY; CONFERENCE PAPER; DIET; ENTERITIS; ENVIRONMENT; HEALTH CARE; HOST; IMMUNOLOGY; INTESTINE; INTESTINE FLORA; LIFESTYLE; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL; RISK;

ANIMAL HUSBANDRY; ANIMALS; DRUG DISCOVERY; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM DISEASES; INFLAMMATORY BOWEL DISEASES; INTESTINES; METAGENOME; NUTRITIONAL STATUS; PROBIOTICS;

EID: 77949355838     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04135.x     Document Type: Conference Paper

References (51)

1. Venter JC. A life decoded. My genome: my life. London: Allen Lane/Penguin, 2007.
2. Turnbaugh PJ, Ley RE, Hamady M et al. The human microbiome project. Nature 2007; 449:804-10.
3. Skrabenek P. Risk factor epidemiology: science or non-science? In: Skrabenek P., ed. False premises false promises.Whithorn: Taragon Press, 1999:153-63.
4. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008; 8:458-66.
5. Mathew CG. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat Rev Genet 2008; 9:9-14.
6. Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 2008; 57:1185-91.
7. Shanahan F, Bernstein CN. The evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol 2009; 25:301-5.
8. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347:911-20.
9. Ivanov II, Frutos Rde L, Manel N et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008; 4:337-49.
10. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134:577-94.
11. Martin HM, Campbell BJ, Hart CA et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004; 127:80-93.
12. Knight P, Campbell BJ, Rhodes JM. Host-bacteria interaction in inflammatory bowel disease. Br Med Bull 2008; 88:95-113.
13. Sibartie S, Scully P, Keohane J et al. Mycobacterium avium subsp. paratuberculosis (MAP) as a modifying factor in Crohn's disease. Inflamm Bowel Dis 2010; 16:296-304.
14. Clayton EM, Rea MC, Shanahan F et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol 2009; 104:1162-9.
15. Peterson DA, Frank DN, Pace NR, Gordon JI. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008; 3:417-27.
16. Sokol H, Pigneur B, Watterlot L et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105:16731-6.
17. Hughes DT, Sperandio V. Inter-kingdom signaling: communication between bacteria and their hosts. Nat Rev Microbiol 2008; 6:111-20.
18. Ryu JH, Kim SH, Lee HY et al. Innate immune homeostasis by the homeobox gene caudal and commensal-gut mutualism in Drosophila. Science 2008; 319:777-82.
19. Suzuki K, Meek B, Doi Y et al. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci USA 2004; 101:1981-6.
20. Garrett WS, Lord GM, Punit S et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007; 131:33-45.
21. Smith AM, Rahman FZ, Hayee B et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 2009; 206:1883-97. Erratum in: J Exp Med 2009; 206:2301.
22. Marks DJ, Rahman FZ, Sewell GW, Segal AW. Crohn's disease: an immune deficiency state. Clin Rev Allergy Immunol 2010; 38: 20-31.
23. Sewell GW, Marks DJB, Segal AW. The immunopathogenesis of Crohn's disease: a three-stage model. Curr Opin Immunol 2009; 21:506-13.
24. Sartor RB. Therapeutic correction of bacterial dysbiosis discovered by molecular techniques. Proc Natl Acad Sci USA 2008; 105:16413-14.
25. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007; 70:461-77.
26. Shanahan F, Kiely B. The gut microbiota and disease - an inner repository for drug discovery. Drug Discov Today Ther Strategies 2007; 4:195-200.
27. Caskey CT. The drug development crisis: efficiency and safety. Annu Rev Med 2007; 58:1-16.
28. Shanahan F, Stanton C, Ross P, Hill C. Pharmabiotics: bioactives from mining host-microbe-dietary interactions. Funct Food Rev 2009; 1:1-6.
29. Rea MC, Clayton E, O'Connor PM et al. Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains. J Med Microbiol 2007; 56:940-6.
30. Grangette C, Nutten S, Palumbo E et al. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci USA 2005; 102: 10321-6.
31. Obermeier F, Dunger N, Strauch UG et al. Contrasting activity of cytosine-guanosine dinucleotide oligonucleotides in mice with experimental colitis. Clin Exp Immunol 2003; 134:217-24.
32. Rachmilewitz D, Katakura K, Karmeli F et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126:520-8.
33. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122:107-18.
34. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453:620-5.
35. Backhed F, Ding H, Wang T et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101:15718-23.
36. Wall R, Ross RP, Shanahan F et al. The metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues. Am J Clin Nutr 2009; 89:1393-401.
37. Rousseaux C, Thuru X, Gelot A et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007; 13:35-7.
38. Cotter PD, Hill C, Ross RP. Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 2005; 3:777-88.
39. Fujiya M, Musch MW, Nakagawa Y et al. The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe 2007; 1:299-308.
40. Yan F, Cao H, Cover TL, Whitehead R et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007; 132:562-75.
41. Bouskra D, Brézillon C, Bérard M et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008; 456:507-10.
42. Hooper LV, Wong MH, Thelin A et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291:881-4.
43. Flint HJ, Duncan SH, Scott KP, Louis P. Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol 2007; 9:1101-11.
44. Li M, Wang B, Zhang Z et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 2008; 105:2117-22.
45. Dumas ME, Barton RH, Toye A et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulinresistant mice. Proc Natl Acad Sci USA 2006; 103:12511-6.
46. Wen L, Ley RE, Volchkov PY et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008; 455:1109-13.
47. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009; 137:1716-24.
48. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996; 63:741-5.
49. Ercolini AM, Miller SD. The role of infections in autoimmune disease. Clin Exp Immunol 2009; 155:1-15.
50. Griffiths P. Time to consider the concept of a commensal virus. Rev Med Virol 1999; 9:73-4.
51. Breitbart M, Haynes M, Kelley S et al. Viral diversity and dynamics in an infant gut. Res Microbiol 2008; 159:367-73.